id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-340029-iv2x1vap	Farabi, Banu	Comment on “Psoriasis, COVID‐19 and acute respiratory distress syndrome: focusing on the risk of concomitant biological treatment”	2020-06-14		.txt	text/plain	811	39	34	showed that there is no death due to COVID-19 and only one hospitalization, fully recovered amongst the patients with chronic plaque psoriasis receiving a biological treatment and renal transplant recipients who were under immunosuppressive therapies (4) . Since, we do not have much data on biologics in psoriasis patients effecting COVID-19 disease course, current data suggests that there is no increase morbidity/ mortality amongst these patients. Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biological treatment and renal transplanted recipients in maintenance immunosuppressive treatment Novel Coronavirus Disease (COVID-19) and Biologic Therapy in Psoriasis: Infection Risk and Patient Counseling in Uncertain Times Safety and effectiveness of conventional systemic therapy and biological drugs in patients with moderate to severe psoriasis and HIV infection: a retrospective multicenter study Psoriasis treatment in HIV-positive patients: a systematic review of systemic immunosuppressive therapies	./cache/cord-340029-iv2x1vap.txt	./txt/cord-340029-iv2x1vap.txt